Latest MedImmune Stories
MERIDEN, Conn., June 17, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that BARDA, within the
The Lung-MAP trial uses a multi-drug, targeted screening approach to match patients with promising new cancer treatments based on their unique tumor profiles BETHESDA, Md., June 16,
Cell-culture technology is a modern alternative to manufacture influenza vaccines without chicken eggs, with potential to rapidly respond to a pandemic BASEL, Switzerland, June 16, 2014
RnRMarketResearch.com adds "Next-Generation Biologics R&D, Industry and Market 2014-2024" on its store.
TUCSON, Ariz., June 4, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the
MERIDEN, Conn., May 30, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that Astellas Pharma has
Editor Note: For more information about this release, please scroll to bottom. NEW YORK, May 20, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts'
LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
The Department of Economic Development for the City of Frederick is proud to announce that AstraZeneca, and its global biologics research and development arm MedImmune, received an “Economic
- In medieval musical notation, a sign or neume denoting a shake or trill.